Sildenafil Tablet, Film Coated
Product Images NDC 68071-3743

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 68071-3743). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3743 3)

Pdp (68071 3743 3)
This text is a label from NuCare Pharmaceuticals Inc., providing details about Sildenafil 50mg tablets. It includes lot numbers, expiration dates, serial numbers, and instructions for usage. There is also a warning to keep the medication out of reach of children and store it at a controlled temperature of 68-77°F. Additionally, it advises contacting a doctor for medical advice and reporting any side effects to the FDA.*
FDA Label Image

Figure 1 (Sildenafil Fig1)

Figure 1 (Sildenafil Fig1)
This is a table showing the change in sitting systolic blood pressure in healthy volunteers before and after taking Sildenafil 100mg or placebo. The table includes pre-dose and post-dose blood pressure readings in mmHg at different time points.*
FDA Label Image

Figure 2 (Sildenafil Fig2)

Figure 2 (Sildenafil Fig2)
This text provides a comparison of the change in systolic blood pressure (SBP) over time post-dose for two different treatments: Doxazosin + Placebo and Doxazosin + Sildenafil 25 mg. The data is presented in a figure depicting the SBP change from baseline at 2, 3, 4, 5, 6, 7, and 8 hours post-dose.*
FDA Label Image

Figure 3 (Sildenafil Fig3)

FDA Label Image

Figure 4 (Sildenafil Fig4)

FDA Label Image

Figure 5 (Sildenafil Fig5)

Figure 5 (Sildenafil Fig5)
This is a data set showing the mean Sildenafil plasma concentrations in healthy male volunteers over time after a commercial tablet dose. The graph likely illustrates the levels of Sildenafil in the blood at different intervals post-dosing, measured in hours.*
FDA Label Image

Figure 6. Effect Of Sildenafil And Placebo On Maintenance Of Erection By Baseline Score (Sildenafil Fig6)

FDA Label Image

Sildenafile Fig 7 (Sildenafil Fig7)

FDA Label Image

Structure (Sildenafil Str)

Structure (Sildenafil Str)
Not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.